Chau CH - Search Results

1

Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.

Schmidt KT, Chau CH, Price DK, Figg WD. Schmidt KT, et al. Among authors: chau ch. J Clin Pharmacol. 2016 Dec;56(12):1484-1499. doi: 10.1002/jcph.765. Epub 2016 Jun 17. J Clin Pharmacol. 2016. PMID: 27197880 Free PMC article. Review.

2

Molecular and phenotypic heterogeneity of metastatic prostate cancer.

Chau CH, Figg WD. Chau CH, et al. Cancer Biol Ther. 2005 Feb;4(2):166-7. doi: 10.4161/cbt.4.2.1571. Epub 2005 Feb 28. Cancer Biol Ther. 2005. PMID: 15738648 Free article. Review.

3

Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancer.

Chau CH, Permenter MG, Steinberg SM, Retter AS, Dahut WL, Price DK, Figg WD. Chau CH, et al. Cancer Biol Ther. 2005 Nov;4(11):1222-5. doi: 10.4161/cbt.4.11.2091. Epub 2005 Nov 11. Cancer Biol Ther. 2005. PMID: 16205110 Free article.

4

Mechanisms of disease: Polymorphisms of androgen regulatory genes in the development of prostate cancer.

Singh AS, Chau CH, Price DK, Figg WD. Singh AS, et al. Among authors: chau ch. Nat Clin Pract Urol. 2005 Feb;2(2):101-7. doi: 10.1038/ncpuro0091. Nat Clin Pract Urol. 2005. PMID: 16474655 Review.

5

Heterogeneity in drug disposition determines interindividual variability of docetaxel pharmacokinetics.

Figg WD, Chau CH. Figg WD, et al. Among authors: chau ch. Cancer Biol Ther. 2006 Jul;5(7):840-1. doi: 10.4161/cbt.5.7.3025. Epub 2006 Jul 12. Cancer Biol Ther. 2006. PMID: 16880730 Free article. No abstract available.

6

Association of a CYP17 polymorphism with overall survival in Caucasian patients with androgen-independent prostate cancer.

Hamada A, Danesi R, Price DK, Sissung T, Chau C, Venzon D, Sparreboom A, Dahut WL, Figg WD. Hamada A, et al. Urology. 2007 Aug;70(2):217-20. doi: 10.1016/j.urology.2007.06.1097. Urology. 2007. PMID: 17826473 Free PMC article.

7

Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer.

Hamada A, Sissung T, Price DK, Danesi R, Chau CH, Sharifi N, Venzon D, Maeda K, Nagao K, Sparreboom A, Mitsuya H, Dahut WL, Figg WD. Hamada A, et al. Among authors: chau ch. Clin Cancer Res. 2008 Jun 1;14(11):3312-8. doi: 10.1158/1078-0432.CCR-07-4118. Clin Cancer Res. 2008. PMID: 18519758 Free PMC article.

8

Pharm. D. pathways to biomedical research: the National Institutes of Health special conference on pharmacy research.

Figg WD, Chau CH, Okita R, Preusch P, Tracy TS, McLeod H, Reed M, Pieper J, Knoell D, Miller K, Speedie M, Blouin R, Kroboth P, Koda-Kimble MA, Taylor P, Cohen J, Giacomini K. Figg WD, et al. Among authors: chau ch. Pharmacotherapy. 2008 Jul;28(7):821-33. doi: 10.1592/phco.28.7.821. Pharmacotherapy. 2008. PMID: 18576897

9

Combining mTOR inhibition with metronomic chemotherapy in targeting angiogenesis.

Chau CH, Wang W, Figg WD. Chau CH, et al. Cancer Biol Ther. 2008 Sep;7(9):1386-7. doi: 10.4161/cbt.7.9.6757. Epub 2008 Sep 6. Cancer Biol Ther. 2008. PMID: 18769127 Free article. No abstract available.

10

Validation of analytic methods for biomarkers used in drug development.

Chau CH, Rixe O, McLeod H, Figg WD. Chau CH, et al. Clin Cancer Res. 2008 Oct 1;14(19):5967-76. doi: 10.1158/1078-0432.CCR-07-4535. Clin Cancer Res. 2008. PMID: 18829475 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters